Octyl methoxycinnamate (CAS 5466-77-3) continues to dominate the API intermediates market as the primary UVB filter in dermatological formulations, where custom synthesis services are increasingly focused on improving its photostability through advanced encapsulation techniques. Ethylhexyl methoxycinnamate remains a cr...